Radiotherapy for breast cancer, the TARGIT - A trial (II)

The Lancet

Volumn 383, Issue 9930, 2014, Pages 1716-

  Cuzick, Jack ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; EXTERNAL BEAM RADIOTHERAPY; HUMAN; LETTER; PATIENT HISTORY OF RADIOTHERAPY; PRIORITY JOURNAL; FOLLOW UP; HYPOTHESIS; KAPLAN MEIER METHOD; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); BREAST TUMOR; FEMALE; NOTE; PAGET NIPPLE DISEASE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS;

EID: 84900555988     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60825-4     Document Type: Letter

References (5)

1. Vaidya JS, Wenz F, Bulsara M., et al, on behalf of the TARGIT trialists' group. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet 2014; 383: 603-13.
2. D'Agostino RB Sr, Massaro JM, Sullivan LM. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics. Stat Med 2003; 22: 169-86.
3. EBCTCG (Early Breast Cancer Trialists' Collaborative Group). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet 2011; 378: 1707-16.
4. Cuzick J. The assessment of subgroups in clinical trials. Experientia Suppl 1982; 41: 224-35.
5. Cuzick J. Forest plots and the interpretation of subgroups. Lancet 2005; 365: 1308.